ProductUpdated on 17 July 2025
Plug-and-Play Molecular Diagnostics: Oncology & Infection Panels for Clinical Labs
CBDO at HQ Science Ltd
London, United Kingdom
About
HQ Science provides a ready-to-use molecular diagnostics platform for oncology and infectious disease testing, designed for effortless integration into clinical workflows.
Our system, Tachyon, is a compact, AI-powered unit that connects directly to Oxford Nanopore sequencers, delivering accurate genomic results within hours. It eliminates the need for costly lab infrastructure, trained bioinformaticians, or complex analysis pipelines.
Key features for clinical partners:
-
Plug-and-play deployment within a day
-
Oncology panels (e.g. recurrence risk) and infectious disease panels
-
Fully automated analysis with clinician-friendly reporting
-
Ongoing CE-IVDR and ISO 13485 certification
-
No hardware purchase required — provided under subscription with sufficient test volume
Current partners include:
Oscar Lambret Cancer Center, UK Health Security Agency, Oslo University Hospital, and Columbia University.
We’re onboarding new clinical sites across Europe. If you’re a diagnostic lab or oncology center looking to expand your molecular testing capabilities — we’d love to talk.
Looking for
- Service
- Product
- Looking for project partners
Organisation
Similar opportunities
Product
£1.5M Round to Scale AI-Powered Diagnostic Platform
- Looking for an investor
Roman Belkin
CBDO at HQ Science Ltd
London, United Kingdom
Product
Grigorios Tsoumakas
Cofounder & Chief Scientific Officer at Medoid AI
Thessaloniki, Greece
Product
Expert Architecture & Full-Lifecycle R&D for AI-Driven SaMD & Digital Therapeutics
- Service
Cristian Cotosman
Solutions Architect and Manager at Moebiusol S.R.L.
Lovrin, Romania